RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer

PURPOSE: Triple-negative breast cancer (TNBC) is highly malignant and has poor prognosis and a high mortality rate. The lack of effective therapy has spurred our investigation of new targets for treating this malignant cancer. Here, we identified RON (macrophage-stimulating 1 receptor) and MET (MET...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Weng, Tian-Hao, Yao, Min-Ya, Xu, Xiang-Ming, Hu, Chen-Yu, Yao, Shu-Hao, Liu, Yi-Zhi, Wu, Zhi-Gang, Tang, Tao-Ming, Fu, Pei-Fen, Wang, Ming-Hai, Yao, Hang-Ping
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373856/
https://ncbi.nlm.nih.gov/pubmed/32324988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2019.726
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados